Lymphoma

Independent Validation of CLARITY MRD Assay Presented

Foresight Diagnostics announced the independent validation of its CLARITY MRD assay, showing strong prognostic performance.

Lymphoma

Foresight Diagnostics Shares Vision of Lymphoma MRD Detection

Foresight's first commercially available test offering will be a CLIA-validated B-cell lymphoma MRD assay.

Lymphoma

Cytek Biosciences Debuts Advanced Five-Laser Flow Cytometer

The Aurora system is now available with five lasers, making it possible for researchers to visualize more than 30 colors from a single sample.

Determining Molecular Response in Chronic Myeloid Leukemia

Nov 9, 2018 | Disease States, Leukemia, Lymphoma, Molecular Diagnostics

Droplet digital PCR can provide a more accurate assessment of low levels of BCR-ABL mRNA than quantitative real-time PCR.

ASCP, ASH, and CAP Invite Public Comment on Lymphoma Guideline

Sep 28, 2018 | Lymphoma

Multidisciplinary guidance document focuses on specimen requirements for the diagnosis of lymphoma.

August/September 2017 Product Spotlight: New Products Showcase

Aug 28, 2017 | Flow Cytometry, Flow Cytometry Instruments, Lymphoma, Microbiology Instruments, Molecular Diagnostics

This month’s Product Spotlight features new products from such companies as Advanced Instruments, Beckman Coulter, and Thermo Fisher Scientific.

HTG Molecular Diagnostics Launches NGS-Based Cell-of-Origin Assay for Diffuse Large B-Cell Lymphomas

Oct 19, 2015 | Lymphoma, Molecular Diagnostics

HTG’s next-generation sequencing assay enables subtyping of DLBCL as activated B-cell-like or germinal center B-cell-like.

NCI Awards $1.4 Million Grant to Advanced Cell Diagnostics

Oct 13, 2014 | Cancer, Lymphoma, Molecular Diagnostics, Research

Under a new grant from the National Cancer Institute, Advanced Cell Diagnostics will partner with the Cleveland Clinic to develop an ultrasensitive diagnostic test for B-cell lymphoma.

PathGroup Collaboration to Offer Genomic Profiling of Hematologic Malignancies

Mar 24, 2014 | Cancer, Leukemia, Lymphoma, Molecular Diagnostics

A new collaboration plans to provide genomic profiling and information for patients that have been unsuccessful on repeated therapy for the group of cancers that include leukemias, lymphomas, and myeloproliferative and myelodysplastic diseases.

Tool Could Help Assessment of Hodgkin’s Lymphoma and Breast Cancer

Dec 24, 2013 | Breast, Cancer, Lymphoma, Research, Unknown Origin & Other Cancer Types

A new study shows the MultiOmyx profile could improve disease assessment for both diseases using multiplex proteins.

Sequenta Expands Sample Types Accepted for ClonoSIGHT MRD Test for Leukemia, Lymphoma

Sep 26, 2013 | Cancer, Lymphoma, Miscellaneous

Ultra-sensitive detection of minimal residual disease now available to more people with blood cancers.

Diagnovus Debuts Gene Expression Assay for Patients With Diffuse Large B-Cell Lymphoma

Feb 21, 2013 | Cancer, Lymphoma, Miscellaneous

Assay can aid physicians in better risk stratification and treatment of patients with diffuse large B-cell lymphoma.

Sequenta Introduces ClonoSIGHT, Sequencing-Based MRD Test for Leukemia, Lymphoma

Feb 14, 2013 | Cancer, Leukemia, Lymphoma, Molecular Diagnostics

The test has been shown to offer sensitivity for the detection of residual cancer cells in marrow or blood.

Testing for Lymphoma and Leukemia

Sep 5, 2006 | Cancer, Leukemia, Lymphoma

With so many types of lymphoma, there’s a wide range of corresponding lab tests to detect their presence in patients. Here, CLP takes a look at testing for the most common type of lymphoma (diffuse large B-cell

Category: Lymphoma

Lymphoma

Lymphoma

Lymphoma